Susan K Logan

Biosketch / Results /

Susan Logan

Associate Professor, Department of Urology;Associate Professor, Department of Biochemistry and Molecular Pharmacology

Contact Info

540-562 First Avenue
New York, NY 10016



1993 — University of California, San Francisco, PostDoctoral Training
— Brandeis University, Graduate Education
1999 — New York University School of Medicine, PostDoctoral Training

Research Summary

Androgen steroid hormones direct the genetic program dictating male development. The phenotypic consequences of mutations in androgen binding receptors include partial or complete feminization in males, sterility and cancer. It is also clear that androgen regulates cell growth although the mechanism is not understood. In particular, growth and differentiation of prostate epithelial cells is strictly regulated in response to circulating androgens and for this reason androgen ablation therapy is commonly used to effect prostate cancer regression. The research goal of my lab is to understand the androgen receptor signal transduction pathway regulating cell growth. The specific goals of the laboratory at this time are to: 1) uncover the role of androgen receptor binding proteins (coactivators and corepressors) in androgen-mediated prostate cell growth 2) develop new mouse models of prostate cancer progression and 3) create phosphorylation-specific anti-androgen receptor antibodies to be used in defining the functional role of androgen receptor in androgen-dependent and androgen-independent prostate cancer. Some of the technologies used in the lab include immunohistochemistry to compare the expression of androgen receptor coactivators in normal and cancer tissue of the prostate and breast, and transgenic mice to determine the oncogenic properties of signaling molecules and coactivators. In addition, the effect of novel molecules on androgen mediated cell cycle progression is determined using tetracycline-inducible cell lines, immunofluorescence analysis, and gene expression arrays. Through these studies we hope to advance our basic understanding of steroid receptor action, as well as provide a basis for new therapeutic approaches in prostate cancer.

Research Interests

Cellular Growth Control and Androgen Receptor

Androgen receptor coactivators that inhibit prostate cancer growth
Daniels, Garrett; Jha, Ruchi; Shen, Ying; Logan, Susan K; Lee, Peng
2014-11-10; 2330-1910,American journal of clinical & experimental urology - id: 1342092, year: 2014 Journal Article; Review

TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth
Daniels, Garrett; Li, Yirong; Gellert, Lan Lin; Zhou, Albert; Melamed, Jonathan; Wu, Xinyu; Zhang, Xinming; Zhang, David; Meruelo, Daniel; Logan, Susan K; Basch, Ross; Lee, Peng
2014-07-29; 1351-0088,Endocrine-related cancer - id: 1083962, year: 2014 Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

Metformin Targets c-MYC Oncogene to Prevent Prostate Cancer
Akinyeke, Tunde; Matsumura, Satoko; Wang, Xinying; Wu, Yingjie; Schalfer, Eric D; Saxena, Anjana; Yan, Wenbo; Logan, Susan K; Li, Xin
2013-10-23; 0143-3334,Carcinogenesis - id: 574312, year: 2013 JOURNAL ARTICLE

Mini-review: androgen receptor phosphorylation in prostate cancer
Daniels, Garrett; Pei, Zhiheng; Logan, Susan K; Lee, Peng
2014-11-09; 2330-1910,American journal of clinical & experimental urology - id: 1341312, year: 2013 Journal Article; Review

Mini-review: androgen receptor phosphorylation in prostrate cancer
Daniels, Garrett; Pei, Zhiheng; Logan, Susan K; Lee, Peng
2014-01-23; 2330-1910,American journal of clinical & experimental urology - id: 745662, year: 2013